• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期使用非那雄胺和度他雄胺的健康风险:是时候敲响警钟了。

Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm.

作者信息

Traish Abdulmaged M

机构信息

Department of Urology, Boston University School of Medicine, Boston, MA, USA.

出版信息

World J Mens Health. 2020 Jul;38(3):323-337. doi: 10.5534/wjmh.200012. Epub 2020 Mar 20.

DOI:10.5534/wjmh.200012
PMID:32202088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7308241/
Abstract

5α-dihydrotestosterone (5α-DHT) is the most potent natural androgen. 5α-DHT elicits a multitude of physiological actions, in a host of tissues, including prostate, seminal vesicles, hair follicles, skin, kidney, and lacrimal and meibomian glands. However, the physiological role of 5α-DHT in human physiology, remains questionable and, at best, poorly appreciated. Recent emerging literature supports a role for 5α-DHT in the physiological function of liver, pancreatic β-cell function and survival, ocular function and prevention of dry eye disease and kidney physiological function. Thus, inhibition of 5α-reductases with finasteride or dutasteride to reduce 5α-DHT biosynthesis in the course of treatment of benign prostatic hyperplasia (BPH) or male pattern hair loss, known as androgenetic alopecia (AGA) my induces a novel form of tissue specific androgen deficiency and contributes to a host of pathophysiological conditions, that are yet to be fully recognized. Here, we advance the concept that blockade of 5α-reductases by finasteride or dutasteride in a mechanism-based, irreversible, inhabitation of 5α-DHT biosynthesis results in a novel state of androgen deficiency, independent of circulating testosterone levels. Finasteride and dutasteride are frequently prescribed for long-term treatment of lower urinary tract symptoms in men with BPH and in men with AGA. This treatment may result in development of non-alcoholic fatty liver diseases (NAFLD), insulin resistance (IR), type 2 diabetes (T2DM), dry eye disease, potential kidney dysfunction, among other metabolic dysfunctions. We suggest that long-term use of finasteride and dutasteride may be associated with health risks including NAFLD, IR, T2DM, dry eye disease and potential kidney disease.

摘要

5α-双氢睾酮(5α-DHT)是效力最强的天然雄激素。5α-DHT在许多组织中引发多种生理作用,包括前列腺、精囊、毛囊、皮肤、肾脏以及泪腺和睑板腺。然而,5α-DHT在人体生理学中的生理作用仍然存疑,而且充其量也未得到充分认识。最近出现的文献支持5α-DHT在肝脏生理功能、胰腺β细胞功能与存活、眼部功能以及预防干眼症和肾脏生理功能方面发挥作用。因此,在治疗良性前列腺增生(BPH)或男性型脱发(即雄激素性脱发,AGA)过程中,用非那雄胺或度他雄胺抑制5α-还原酶以减少5α-DHT生物合成,可能会引发一种新的组织特异性雄激素缺乏形式,并导致许多尚未被充分认识的病理生理状况。在此,我们提出这样一个概念,即非那雄胺或度他雄胺以基于机制的、不可逆的方式抑制5α-DHT生物合成,从而阻断5α-还原酶,会导致一种独立于循环睾酮水平的新的雄激素缺乏状态。非那雄胺和度他雄胺经常被用于长期治疗患有BPH的男性和患有AGA的男性的下尿路症状。这种治疗可能会导致非酒精性脂肪性肝病(NAFLD)、胰岛素抵抗(IR)、2型糖尿病(T2DM)、干眼症、潜在的肾功能障碍以及其他代谢功能障碍。我们认为,长期使用非那雄胺和度他雄胺可能与包括NAFLD、IR、T2DM、干眼症和潜在肾病在内的健康风险相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/42ab272b612b/wjmh-38-323-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/d52599cc682e/wjmh-38-323-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/32b098baa90d/wjmh-38-323-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/0276dcf005a3/wjmh-38-323-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/80e6c23250af/wjmh-38-323-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/0edb386d83eb/wjmh-38-323-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/42ab272b612b/wjmh-38-323-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/d52599cc682e/wjmh-38-323-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/32b098baa90d/wjmh-38-323-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/0276dcf005a3/wjmh-38-323-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/80e6c23250af/wjmh-38-323-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/0edb386d83eb/wjmh-38-323-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eee8/7308241/42ab272b612b/wjmh-38-323-g006.jpg

相似文献

1
Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm.长期使用非那雄胺和度他雄胺的健康风险:是时候敲响警钟了。
World J Mens Health. 2020 Jul;38(3):323-337. doi: 10.5534/wjmh.200012. Epub 2020 Mar 20.
2
Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.男性睾酮缺乏和 5α-还原酶抑制剂治疗对代谢和性功能的负面影响。
Adv Exp Med Biol. 2017;1043:473-526. doi: 10.1007/978-3-319-70178-3_22.
3
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.双氢睾酮与人类良性前列腺增生中5α-还原酶抑制的概念。
World J Urol. 2002 Apr;19(6):413-25. doi: 10.1007/s00345-002-0248-5.
4
Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.双氢睾酮与人类良性前列腺增生中5α-还原酶抑制的概念
Eur Urol. 2000 Apr;37(4):367-80. doi: 10.1159/000020181.
5
Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia.非那雄胺,一种2型5α-还原酶抑制剂,用于治疗男性雄激素性脱发。
Expert Opin Investig Drugs. 1999 Apr;8(4):403-15. doi: 10.1517/13543784.8.4.403.
6
Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.双氢睾酮与前列腺:5α还原酶抑制剂治疗良性前列腺增生的科学依据。
J Urol. 2004 Oct;172(4 Pt 1):1399-403. doi: 10.1097/01.ju.0000139539.94828.29.
7
Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair.通过测量毛发中的非那雄胺、度他雄胺和二氢睾酮来评估雄激素性脱发药物的治疗效果。
Clin Chim Acta. 2023 Jul 1;547:117456. doi: 10.1016/j.cca.2023.117456. Epub 2023 Jun 28.
8
Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor.双重5α-还原酶抑制剂度他雄胺可显著抑制良性前列腺增生男性体内的双氢睾酮。
J Clin Endocrinol Metab. 2004 May;89(5):2179-84. doi: 10.1210/jc.2003-030330.
9
New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.新型甾体 17β-羧基衍生物在雄激素反应性人前列腺癌细胞系中具有抗 5α-还原酶活性和抗增殖作用。
Biochimie. 2013 Nov;95(11):2097-106. doi: 10.1016/j.biochi.2013.07.023. Epub 2013 Aug 9.
10
Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?5α-还原酶抑制剂的不良反应:我们知道什么、不知道什么以及需要知道什么?
Rev Endocr Metab Disord. 2015 Sep;16(3):177-98. doi: 10.1007/s11154-015-9319-y.

引用本文的文献

1
The pathogenesis of benign prostatic hyperplasia and the roles of Prdx3, oxidative stress, pyroptosis and autophagy:a review.良性前列腺增生的发病机制以及Prdx3、氧化应激、细胞焦亡和自噬的作用:综述
Front Oncol. 2025 Aug 5;15:1579539. doi: 10.3389/fonc.2025.1579539. eCollection 2025.
2
Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024.非那雄胺不良事件的多维评估:基于2004年至2024年4月美国食品药品监督管理局不良事件报告系统(FAERS)的真实世界药物警戒分析
PLoS One. 2025 Mar 24;20(3):e0309849. doi: 10.1371/journal.pone.0309849. eCollection 2025.
3

本文引用的文献

1
Post-finasteride syndrome: a surmountable challenge for clinicians.前列腺素后综合征:临床医生可克服的挑战。
Fertil Steril. 2020 Jan;113(1):21-50. doi: 10.1016/j.fertnstert.2019.11.030.
2
Role of Hepatic Glucocorticoid Receptor in Metabolism in Models of 5αR1 Deficiency in Male Mice.肝糖皮质激素受体在 5αR1 缺乏雄性小鼠模型代谢中的作用。
Endocrinology. 2019 Sep 1;160(9):2061-2073. doi: 10.1210/en.2019-00236.
3
Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage-Animal, Experimental Study.非那雄胺抑制 5α-还原酶 2 可能导致肾脏损伤——动物实验研究。
Post-finasteride syndrome - a true clinical entity?
非那雄胺后综合征——一种真实的临床病症?
Int J Impot Res. 2025 Feb 14. doi: 10.1038/s41443-025-01025-6.
4
Clinician's guide to the management of azoospermia induced by exogenous testosterone or anabolic-androgenic steroids.外源性睾酮或合成代谢雄激素类固醇所致无精子症的临床处理指南
Asian J Androl. 2025 May 1;27(3):330-341. doi: 10.4103/aja2024104. Epub 2025 Jan 17.
5
Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review.度他雄胺与非那雄胺在男性和女性雄激素性秃发的毛发生长及毛囊小型化逆转方面的比较:一项系统评价
Dermatol Reports. 2024 Apr 12;16(4):9909. doi: 10.4081/dr.2024.9909. eCollection 2024 Nov 21.
6
The association between lower urinary tract symptoms secondary to benign prostatic hyperplasia and multimorbidity among Chinese middle-aged and elderly males: evidence based on propensity score matching.中国中老年男性良性前列腺增生继发下尿路症状与多种疾病的关联:基于倾向得分匹配的证据
Transl Androl Urol. 2024 Sep 30;13(9):1932-1945. doi: 10.21037/tau-24-268. Epub 2024 Sep 26.
7
Zhuangyao Jianshen pill ameliorates testosterone-induced benign postatic hyperplasia in rats.壮瑶健肾丸可改善睾丸酮诱导的大鼠良性前列腺增生。
J Tradit Chin Med. 2024 Aug;44(4):694-702. doi: 10.19852/j.cnki.jtcm.20240627.001.
8
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease.糖皮质激素在代谢相关脂肪性肝病中的作用。
Curr Obes Rep. 2024 Jun;13(2):242-255. doi: 10.1007/s13679-024-00556-1. Epub 2024 Mar 8.
9
Hair Transplantation in the United States: A Population-based Survey of Female and Male Pattern Baldness.美国的毛发移植:一项基于人群的男女型秃发调查。
Plast Reconstr Surg Glob Open. 2023 Nov 13;11(11):e5386. doi: 10.1097/GOX.0000000000005386. eCollection 2023 Nov.
10
The post-finasteride syndrome: possible etiological mechanisms and symptoms.非那雄胺后综合征:可能的病因机制及症状
Int J Impot Res. 2023 Sep 11. doi: 10.1038/s41443-023-00759-5.
Int J Environ Res Public Health. 2019 May 16;16(10):1726. doi: 10.3390/ijerph16101726.
4
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study.接受类固醇 5α-还原酶抑制剂的男性 2 型糖尿病发病率:基于人群的队列研究。
BMJ. 2019 Apr 10;365:l1204. doi: 10.1136/bmj.l1204.
5
MECHANISMS IN ENDOCRINOLOGY: Hormonal regulation of spermatogenesis: mutant mice challenging old paradigms.内分泌学机制:精子发生的激素调节:挑战旧范式的突变小鼠。
Eur J Endocrinol. 2018 Sep;179(3):R143-R150. doi: 10.1530/EJE-18-0396. Epub 2018 Jun 29.
6
Possible mechanisms underlying fatty liver in a rat model of male hypogonadism: A protective role for testosterone.雄性性腺功能减退大鼠模型中脂肪肝的潜在机制:睾酮的保护作用。
Steroids. 2018 Jul;135:21-30. doi: 10.1016/j.steroids.2018.04.004. Epub 2018 Apr 17.
7
Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer.男性前列腺癌雄激素剥夺治疗相关的肝脏疾病。
J Urol. 2018 Sep;200(3):573-581. doi: 10.1016/j.juro.2018.03.135. Epub 2018 Apr 16.
8
Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.男性睾酮缺乏和 5α-还原酶抑制剂治疗对代谢和性功能的负面影响。
Adv Exp Med Biol. 2017;1043:473-526. doi: 10.1007/978-3-319-70178-3_22.
9
Evaluation of a novel dry eye model induced by oral administration of finasteride.评价一种新型的通过口服非那雄胺诱导的干眼症模型。
Mol Med Rep. 2017 Dec;16(6):8763-8770. doi: 10.3892/mmr.2017.7754. Epub 2017 Oct 10.
10
Free testosterone concentration is inversely associated with markers of liver fibrosis in men with type 2 diabetes mellitus.在2型糖尿病男性患者中,游离睾酮浓度与肝纤维化指标呈负相关。
Endocr J. 2017 Dec 28;64(12):1137-1142. doi: 10.1507/endocrj.EJ17-0225. Epub 2017 Sep 9.